Literature DB >> 20077563

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.

Guadalupe Garcia-Tsao1, Scott Friedman, John Iredale, Massimo Pinzani.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20077563      PMCID： PMC2882065          DOI： 10.1002/hep.23478

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  31 in total

1.  Portal hypertension in chronic hepatitis: relationship to morphological changes.

Authors:  D J van Leeuwen; S C Howe; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

Review 2.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

3.  Correlation between liver morphology and portal pressure in alcoholic liver disease.

Authors:  K Krogsgaard; C Gluud; J H Henriksen; P Christoffersen
Journal:  Hepatology       Date:  1984 Jul-Aug       Impact factor: 17.425

4.  Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage.

Authors:  R J Groszmann; J Bosch; N D Grace; H O Conn; G Garcia-Tsao; M Navasa; J Alberts; J Rodes; R Fischer; M Bermann
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

5.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Authors:  Arie Regev; Mariana Berho; Lennox J Jeffers; Clara Milikowski; Enrique G Molina; Nikolaos T Pyrsopoulos; Zheng-Zhou Feng; K Rajender Reddy; Eugene R Schiff
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

Review 6.  Prevention of variceal rebleeding.

Authors:  Jaume Bosch; Juan Carlos García-Pagán
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

7.  The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization.

Authors:  P P Anthony; K G Ishak; N C Nayak; H E Poulsen; P J Scheuer; L H Sobin
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

Review 8.  Angiogenesis in chronic inflammatory liver disease.

Authors:  Jesús Medina; Alicia G Arroyo; Francisco Sánchez-Madrid; Ricardo Moreno-Otero
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

9.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

10.  Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.

Authors:  Cristina Ripoll; Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Norman Grace; Andrew Burroughs; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; Robert Makuch; David Patch; Daniel S Matloff
Journal:  J Hepatol       Date:  2009-03-05       Impact factor: 25.083
View more
  143 in total

1.  Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging.

Authors:  Hervé Gouya; Sophie Grabar; Olivier Vignaux; Anastasia Saade; Stanislas Pol; Paul Legmann; Philippe Sogni
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

Review 2.  Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.

Authors:  Ken Shirabe; Yuki Bekki; Dolgormaa Gantumur; Kenichiro Araki; Norihiro Ishii; Atsushi Kuno; Hisashi Narimatsu; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2018-01-09       Impact factor: 7.527

3.  Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Authors:  Dimitrios N Samonakis; Mairi Koulentaki; Constantina Coucoutsi; Aikaterini Augoustaki; Chryssavgi Baritaki; Emmanuel Digenakis; Nikolaos Papiamonis; Maria Fragaki; Erminia Matrella; Maria Tzardi; Elias A Kouroumalis
Journal:  World J Hepatol       Date:  2014-07-27

Review 4.  Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

Authors:  Moon Young Kim; Woo Kyoung Jeong; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

5.  Liver-related Events in Human Immunodeficiency Virus-infected Persons With Occult Cirrhosis.

Authors:  Amine Benmassaoud; Roy Nitulescu; Thomas Pembroke; Alex S Halme; Peter Ghali; Marc Deschenes; Philip Wong; Marina B Klein; Giada Sebastiani
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

Review 6.  Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.

Authors:  Ki Tae Suk; Dong Joon Kim
Journal:  World J Hepatol       Date:  2015-03-27

7.  Transient elastography in Canada: current state and future directions.

Authors:  Mohammed Aljawad; Sanjeev Sirpal; Eric M Yoshida; Natasha Chandok
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-12

8.  Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.

Authors:  Vincenzo La Mura; Giulia Tosetti; Massimo Primignani; Francesco Salerno
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

9.  Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.

Authors:  Vincent Lo Re; Bret Zeldow; Michael J Kallan; Janet P Tate; Dena M Carbonari; Sean Hennessy; Jay R Kostman; Joseph K Lim; Matthew Bidwell Goetz; Robert Gross; Amy C Justice; Jason A Roy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-07-19       Impact factor: 2.890

10.  EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study.

Authors:  Jason Y Huang; Jason B Samarasena; Takeshi Tsujino; John Lee; Ke-Qin Hu; Christine E McLaren; Wen-Pin Chen; Kenneth J Chang
Journal:  Gastrointest Endosc       Date:  2016-09-29       Impact factor: 9.427
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.